- Home
- ABVC vs IPA Comparison
ABVC vs IPA Comparison
Compare ABVC & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- IPA
- Stock Information
- Founded
- ABVC 2015
- IPA 1983
- Country
- ABVC United States
- IPA United States
- Employees
- ABVC N/A
- IPA N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- ABVC Health Care
- IPA Health Care
- Exchange
- ABVC Nasdaq
- IPA Nasdaq
- Market Cap
- ABVC 18.8M
- IPA 20.6M
- IPO Year
- ABVC N/A
- IPA 2017
- Fundamental
- Price
- ABVC $1.46
- IPA $0.50
- Analyst Decision
- ABVC
- IPA Strong Buy
- Analyst Count
- ABVC 0
- IPA 2
- Target Price
- ABVC N/A
- IPA $4.00
- AVG Volume (30 Days)
- ABVC 248.3K
- IPA 341.2K
- Earning Date
- ABVC 04-30-2025
- IPA 03-28-2025
- Dividend Yield
- ABVC N/A
- IPA N/A
- EPS Growth
- ABVC N/A
- IPA N/A
- EPS
- ABVC N/A
- IPA N/A
- Revenue
- ABVC $508,383.00
- IPA $16,581,105.00
- Revenue This Year
- ABVC $735.18
- IPA $4.67
- Revenue Next Year
- ABVC N/A
- IPA $14.15
- P/E Ratio
- ABVC N/A
- IPA N/A
- Revenue Growth
- ABVC 1904.43
- IPA 1.34
- 52 Week Low
- ABVC $0.40
- IPA $0.27
- 52 Week High
- ABVC $1.40
- IPA $1.36
- Technical
- Relative Strength Index (RSI)
- ABVC 64.11
- IPA 61.95
- Support Level
- ABVC $1.18
- IPA $0.44
- Resistance Level
- ABVC $1.36
- IPA $0.48
- Average True Range (ATR)
- ABVC 0.14
- IPA 0.03
- MACD
- ABVC 0.05
- IPA 0.00
- Stochastic Oscillator
- ABVC 63.74
- IPA 85.21
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.